American Journal of Cardiovascular Drugs

Articles Available on Medscape

• Apixaban Use in Obese Patients
  This review summarizes available data on the benefits and risks of apixaban in obese patients. Is dose adjustment necessary in these patients?

  November 21, 2022

• Complementary Pharmacotherapy for STEMI Undergoing Primary PCI
  This review provides an evidence-based update to complementary pharmacotherapy for STEMI patients undergoing primary PCI.

  October 06, 2022

• A Comprehensive Approach to Managing Methamphetamine Associated Cardiomyopathy
  Methamphetamine-associated cardiomyopathy is a serious but reversible complication of illicit methamphetamine use. Review its pathophysiology and a holistic approach to management in this paper.

  August 01, 2022

• Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension
  This paper presents an overview of current and emerging classes of antihypertensive drugs, highlighting several novel agents in preclinical trials which show promise in blood pressure management.

  May 23, 2022

• Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
  This review summarizes the main characteristics of statins, ezetimibe, and PCSK9 inhibitors as well as emerging lipid-lowering therapies which will further expand the available armamentarium.

  April 04, 2022

Table of Contents

2021 -

• Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia. 

  February 04, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Use of Ranolazine for the Treatment of Coronary Microvascular Dysfunction. 

  January 13, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]